Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota
Top Cited Papers
Open Access
- 9 April 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-9
Abstract
Many studies have reported abnormal gut microbiota in individuals with Autism Spectrum Disorders (ASD), suggesting a link between gut microbiome and autism-like behaviors. Modifying the gut microbiome is a potential route to improve gastrointestinal (GI) and behavioral symptoms in children with ASD, and fecal microbiota transplant could transform the dysbiotic gut microbiome toward a healthy one by delivering a large number of commensal microbes from a healthy donor. We previously performed an open-label trial of Microbiota Transfer Therapy (MTT) that combined antibiotics, a bowel cleanse, a stomach-acid suppressant, and fecal microbiota transplant, and observed significant improvements in GI symptoms, autism-related symptoms, and gut microbiota. Here, we report on a follow-up with the same 18 participants two years after treatment was completed. Notably, most improvements in GI symptoms were maintained, and autism-related symptoms improved even more after the end of treatment. Important changes in gut microbiota at the end of treatment remained at follow-up, including significant increases in bacterial diversity and relative abundances of Bifidobacteria and Prevotella. Our observations demonstrate the long-term safety and efficacy of MTT as a potential therapy to treat children with ASD who have GI problems, and warrant a double-blind, placebo-controlled trial in the future.Keywords
Funding Information
- This work was supported by Finch Therapeutics and the Arizona Board of Regents.
This publication has 54 references indexed in Scilit:
- Differences in fecal microbial metabolites and microbiota of children with autism spectrum disordersAnaerobe, 2018
- Diagnosis and Treatment ofClostridium difficilein AdultsJAMA, 2015
- Using the Autism Detection in Early Childhood (ADEC) and Childhood Autism Rating Scales (CARS) to Predict Long Term Outcomes in Children with Autism Spectrum DisordersJournal of Autism and Developmental Disorders, 2014
- Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental DisordersCell, 2013
- Molecular Characterisation of Gastrointestinal Microbiota of Children With Autism (With and Without Gastrointestinal Dysfunction) and Their Neurotypical SiblingsAutism Research, 2012
- Genetic Heritability and Shared Environmental Factors Among Twin Pairs With AutismArchives of General Psychiatry, 2011
- Pyrosequencing study of fecal microflora of autistic and control childrenAnaerobe, 2010
- Recent advances in proton pump inhibitors and management of acid-peptic disordersBioorganic & Medicinal Chemistry, 2007
- Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogenJournal of Neural Transmission, 2003
- THE EXPERIENCE OF DYING WITH DEMENTIA: A RETROSPECTIVE STUDYInternational Journal of Geriatric Psychiatry, 1997